Tonix Pharmaceuticals Holding Corp. (TNXP)
12.43
-0.12
(-0.96%)
USD |
NASDAQ |
Aug 24, 16:00
12.43
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Total Assets (Quarterly) : 254.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 254.09M |
| March 31, 2026 | 257.91M |
| December 31, 2025 | 277.17M |
| September 30, 2025 | 252.44M |
| June 30, 2025 | 187.36M |
| March 31, 2025 | 192.87M |
| December 31, 2024 | 162.89M |
| September 30, 2024 | 94.99M |
| June 30, 2024 | 70.31M |
| March 31, 2024 | 135.34M |
| December 31, 2023 | 154.46M |
| September 30, 2023 | 139.28M |
| June 30, 2023 | 159.74M |
| March 31, 2023 | 179.09M |
| December 31, 2022 | 225.69M |
| September 30, 2022 | 242.65M |
| June 30, 2022 | 276.16M |
| March 31, 2022 | 223.72M |
| December 31, 2021 | 240.90M |
| September 30, 2021 | 214.77M |
| June 30, 2021 | 189.16M |
| March 31, 2021 | 183.52M |
| December 31, 2020 | 98.18M |
| September 30, 2020 | 67.62M |
| June 30, 2020 | 58.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.93M |
| December 31, 2019 | 14.56M |
| September 30, 2019 | 12.27M |
| June 30, 2019 | 15.01M |
| March 31, 2019 | 20.02M |
| December 31, 2018 | 26.32M |
| September 30, 2018 | 16.06M |
| June 30, 2018 | 18.36M |
| March 31, 2018 | 20.98M |
| December 31, 2017 | 26.75M |
| September 30, 2017 | 30.54M |
| June 30, 2017 | 35.82M |
| March 31, 2017 | 23.78M |
| December 31, 2016 | 27.51M |
| September 30, 2016 | 29.80M |
| June 30, 2016 | 34.32M |
| March 31, 2016 | 31.35M |
| December 31, 2015 | 47.02M |
| September 30, 2015 | 57.82M |
| June 30, 2015 | 50.93M |
| March 31, 2015 | 60.47M |
| December 31, 2014 | 39.54M |
| September 30, 2014 | 47.33M |
| June 30, 2014 | 45.06M |
| March 31, 2014 | 50.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Exelixis, Inc. | 2.494B |
| Inovio Pharmaceuticals, Inc. | 49.39M |
| Heron Therapeutics, Inc. | 252.26M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.81M |
| Shareholders Equity (Quarterly) | 222.28M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 6.608 |
| Net Debt Paydown Yield | -0.07% |